Actionnariat et activité des initiés pour Lexicon Pharmaceuticals, Inc. (LXRX): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.02 |
| Capitalisation | $897M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-06-03 | Swain Judith L | M-Exempt | 89,312 | |
| 2026-06-03 | Swain Judith L | M-Exempt | 89,312 | |
| 2026-06-03 | Sullivan Diane E. | M-Exempt | 89,312 | |
| 2026-06-03 | Sullivan Diane E. | M-Exempt | 89,312 | |
| 2026-06-03 | SOBECKI CHRISTOPHER J | M-Exempt | 89,312 | |
| 2026-06-03 | SOBECKI CHRISTOPHER J | M-Exempt | 89,312 | |
| 2026-06-03 | Cheung Ivan | M-Exempt | 89,312 | |
| 2026-06-03 | Cheung Ivan | M-Exempt | 89,312 | |
| 2026-06-03 | BARKER SAM L | M-Exempt | 89,312 | |
| 2026-06-03 | BARKER SAM L | M-Exempt | 89,312 |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $346.5M | $310.8M | $160.1M | $36.1M | $126.3M | $64.1M | $46.3M | $22.5M | $66.7M | $34.3M |
| Placements à Court Terme | 0 | 0 | 0 | $235.5M | $26.0M | $22.7M | $92.0M | $147.6M | $171.3M | $61.9M |
| Créances | $7.5M | $4.8M | $5.9M | $56.5M | $395000 | $14000 | $28000 | $1.0M | $3.5M | $2.4M |
| Stocks | 0 | $1.9M | $4.7M | $4.2M | 0 | 0 | 0 | $381000 | $231000 | $281000 |
| Actifs Courants | $357.9M | $322.0M | $173.3M | $337.8M | $157.7M | $88.9M | $140.9M | $176.5M | $246.2M | $101.9M |
| Immobilisations Corporelles | $19.4M | $17.7M | $15.9M | $14.0M | $295000 | $3.4M | $8.5M | $7.5M | $7.3M | $9.2M |
| Goodwill | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M |
| Actifs Incorporels | $53.4M | $51.9M | $50.1M | $19.7M | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $475.6M | $436.5M | $284.1M | $417.7M | $203.8M | $136.9M | $194.3M | $229.4M | $298.4M | $185.0M |
| Dettes Fournisseurs | $52.9M | $38.8M | $12.1M | $12.2M | $5.5M | $9.2M | $10.4M | $14.4M | $14.8M | $3.1M |
| Dette à Court Terme | $16.3M | $14.1M | $1.1M | $11.0M | $11.6M | 0 | 0 | 0 | 0 | $6.2M |
| Passifs Courants | $164.6M | $124.1M | $36.8M | $65.3M | $46.8M | $22.1M | $23.2M | $31.5M | $45.2M | $20.9M |
| Dette à Long Terme | $85.2M | $231.6M | $243.9M | $234.2M | 0 | 0 | $48.6M | $99.5M | $100.3M | $49.4M |
| Passifs Totaux | $318.2M | $384.4M | $310.5M | $300.6M | $47.4M | $23.3M | $77.2M | $136.3M | $152.5M | $77.4M |
| Réserves | -$1.25B | -$1.38B | -$1.47B | -$1.34B | -$1.40B | -$1.49B | -$1.59B | -$1.77B | -$1.97B | -$2.02B |
| Capitaux Propres | $157.4M | $52.1M | -$1.47B | $117.1M | $156.4M | $113.6M | $117.1M | $93.1M | $145.9M | $107.5M |
| Dette Totale | $101.4M | $245.7M | $245.0M | $246.8M | $12.8M | $2.3M | $55.3M | $106.1M | $108.4M | $62.2M |
| Dette Nette | -$245.1M | -$65.1M | $85.0M | -$24.8M | -$139.5M | -$84.5M | -$83.1M | -$64.0M | -$129.6M | -$34.0M |
| Fonds de Roulement | $193.2M | $197.9M | $136.6M | $272.4M | $110.9M | $66.8M | $117.7M | $145.0M | $200.9M | $81.0M |
Santé financière
| Dette / Capitaux propres | 0.34 |
| Ratio de liquidité | 13.37 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -12.11 |
Rentabilité
| Rentabilité des capitaux propres | -40.40% |
| Rentabilité du capital investi | -23.00% |
| Rentabilité des actifs | -24.44% |
| Marge brute | 98.85% |
| Marge opérationnelle | -131.43% |
| Marge nette | -147.38% |
Entreprises liées: ADCT · BCYC · CMPX · FDMT · FULC · GOSS · NMRA
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de LXRX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions